4 completed, 1 terminated. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Early Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tofacitinib Citrate: new trials by email Literature Review of Tofacitinib Citrate trials Research Report on Tofacitinib Citrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis Tofacitinib Citrate, placebo ointment - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | CAGE Bio Inc. | 40 | 2022-11-09 | 2025-02-13 |
| Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study Tofacitinib Citrate - Healthy Subjects | Phase 1 | Completed | TWi Biotechnology, Inc. | 20 | 2020-10-14 | 2026-10-15 |
| Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers HL-TOF tab. 5mg, Xeljanz tab. 5mg - Healthy Volunteers | Phase 1 | Completed | Hanlim Pharm. Co., Ltd. | 33 | 2019-11-06 | 2020-05-12 |
| Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Tofacitinib citrate - Discoid Lupus Erythematosus, Systemic Lupus Erythematosus | Early Phase 1 | Terminated | Tufts Medical Center | 5 | 2017-04-03 | 2022-01-21 |
| Study of Tofacitinib in Refractory Dermatomyositis Tofacitinib - Dermatomyositis | Phase 1 | Completed | Johns Hopkins University | 10 | 2017-01-01 | 2020-11-06 |
Dermatitis, Atopic (1) · Dermatomyositis (1) · Lupus Erythematosus, Discoid (1) · Lupus Erythematosus, Systemic (1)
CAGE Bio Inc. (1) · Hanlim Pharm. Co., Ltd. (1) · Johns Hopkins University (1) · TWi Biotechnology, Inc. (1) · Tufts Medical Center (1)
United States (2) · Canada (1) · Georgia (1) · South Korea (1)
David Rosmarin, MD (1) · Julie Paik, MD (1)